What BioRender is
BioRender is a web-based tool for creating scientific illustrations, aimed squarely at the life sciences. Its substance is a library of tens of thousands of biological icons — cells, receptors, organelles, model organisms, lab equipment, anatomy — all drawn in one consistent visual style, which you arrange on a canvas with templates for common figure types.
The problem it solved was real and expensive. A pathway diagram or a methods schematic used to mean either hiring an illustrator, spending hours in a vector editor, or producing something that looked hand-drawn in a paper that was not. BioRender turns that into an assembly task, and because every icon shares a style, the result looks professionally illustrated whether or not you can draw. That consistency is genuinely the product — the icons individually are unremarkable, and the fact that they belong together is what makes the output credible.
Why researchers use it
- The icon library — a receptor, a pipette, a mouse, and a mitochondrion that all look like they came from the same illustrator, because they did.
- Templates for standard figure types — pathway diagrams, experimental timelines, graphical abstracts, so you start from a structure rather than a blank canvas.
- Speed — a credible methods schematic in an afternoon instead of two days, which is the honest measure of its value.
- Consistency across a paper — every diagram in a manuscript sharing a visual language raises perceived rigour in a way that is unfair and entirely real.
- Publication licensing on paid tiers — a defined right to use figures in a journal article, which is exactly the question that catches people out.
Where it fits in a research workflow
BioRender occupies the conceptual-illustration slot in a life-sciences paper: the schematic explaining your experimental design, the pathway your intervention targets, the graphical abstract the journal now requires. It is not a data tool and it is not a general figure editor.
That places it beside rather than instead of the rest of your figure stack. Data plots come from matplotlib, ggplot2, or GraphPad Prism; Inkscape does composition, annotation, and anything requiring real LaTeX notation; and if the diagram is boxes and arrows rather than biology, diagrams.net is faster and free. A common arrangement is to build the schematic in BioRender, export SVG, and assemble the multi-panel figure in Inkscape.
Getting started
An afternoon to a usable figure, and settle the licence question before you invest in one.
- Use the free tier to build a real figure from your current project. The output is watermarked and export is limited, which is enough to judge whether the icon library covers your subject matter.
- Start from a template rather than a blank canvas. The templates encode layout conventions that readers in your field already expect, and deviating from them should be a decision rather than an accident.
- Search icons by biological term rather than browsing. The library is large enough that browsing is slower than asking.
- The step people skip: read the publication licence terms before the figure is in a submitted manuscript. Which tier grants what rights, and what happens to those rights if your subscription lapses, are questions with specific answers that matter at proof stage.
BioRender vs the alternatives
| Alternative | Does it better | Pick it if |
|---|---|---|
| Inkscape | Total control, real LaTeX, no subscription, any discipline | You want the figure to be yours and are willing to learn |
| diagrams.net | Flowcharts, study designs, and PRISMA diagrams; free | The figure is structural rather than biological |
| Canva | Posters, slides, and general layout | The deliverable is a poster, not a journal figure |
| An illustrator | Distinctiveness and genuine visual argument | The figure is the centrepiece of a high-profile paper |
BioRender wins decisively on output-per-hour for biology schematics. It loses on cost, on distinctiveness, and on everything outside the life sciences.
Cost, licensing, and your data
Freemium, and the free tier is deliberately limited — watermarked exports and restricted resolution, which is enough to evaluate and not enough to publish. Paid academic tiers unlock high-resolution export and, critically, the publication licence. Institutional and lab plans exist and are common in well-funded departments.
Licensing is the part to take seriously, because it is unusual in this directory. Most figure tools give you unrestricted rights to what you make; BioRender’s icons are licensed, and your right to use a figure in a publication depends on your subscription tier. Commercial use, book chapters, and teaching materials sold for money can all fall outside the standard academic grant. Check the current terms against your intended use before submission, and be aware that a lapsed subscription raises questions about figures already in print that you would rather have answered in advance.
The honest review
Strengths. The output-per-hour is unmatched for biological schematics, and the consistency across a paper’s figures does real work — a manuscript whose diagrams share a visual language reads as more carefully prepared, and reviewers respond to that whether or not they should. For a lab producing many pathway and methods figures, the time saved is substantial and easy to measure.
Limitations. Every BioRender figure looks like a BioRender figure. The house style is now recognisable enough that a reader can identify it at a glance, and distinctiveness — which matters for a cover image or a field-defining paper — costs real extra effort. Publication-quality export is behind a subscription, which turns a figure tool into a recurring cost tied to your ability to publish. The library is biology-centric, so physics, chemistry, engineering, and social science gain nothing. And you are building on licensed assets rather than owning your figure outright, which is a different relationship from every other tool here.
Verdict. Adopt it if you are in the life sciences and produce schematics regularly — the time saved justifies a subscription, especially an institutional one. Skip it outside biology, skip it for data figures, and skip the free tier for anything you intend to publish, since it cannot produce publishable output. The condition that flips the answer is discipline: inside the library’s coverage it is excellent, outside it there is nothing there.
Common questions
Is BioRender free?
There is a free tier, but exports are watermarked and resolution-limited, so it is suitable for drafts and evaluation rather than publication. Paid academic tiers unlock high-resolution export and publication rights; institutional plans are common.
Can I publish BioRender figures in a journal?
On a paid tier with the appropriate publication licence, yes — that is what the tier buys. Confirm the current terms against your specific use, since commercial contexts, book chapters, and sold teaching materials may fall outside the standard academic grant.
Is BioRender useful outside biology?
Little. The icon library is life-sciences-focused, so physics, chemistry, engineering, and social science get almost nothing from it. Inkscape or diagrams.net are the general-purpose alternatives.